Viking Therapeutics, Inc. (VKTX)

Viking Therapeutics, Inc. (VKTX) is a healthcare company (biotechnology) based in the United States. The share price is $26.88, up 0.30% on the day, which values the company at $3.43B. Price as of 18 Nov 2026, 09:47 UTC, from Yahoo Finance.

Key facts

Share price
$26.88+0.30% today
Market value
$3.43B
200-week average
$34.0321% below
Sector
Healthcare

Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

Viking Therapeutics, Inc. in more detail

VKTX trades at -5.2× next year's expected earnings. It sits 21% below its 200-week average of $34.03.

In its favour: More cash than debt. Worth checking: Weak Piotroski score; Share count keeps rising.

Viking Therapeutics, Inc. (VKTX): questions and answers

What is Viking Therapeutics, Inc.'s market cap?

Viking Therapeutics, Inc. is valued at $3.43B at a share price of $26.88.

Is VKTX above its 200-week moving average?

No. VKTX is 21.0% below its 200-week average of $34.03. Long-term investors watch that line because strong companies rarely trade below it for long.

Does VKTX pay a dividend?

Viking Therapeutics, Inc. does not currently pay a regular dividend.

Cite this page

Funkfolio, “Viking Therapeutics, Inc. (VKTX) stock: price, valuation and fundamentals”, data as of 18 November 2026. https://funkfolio.com/stock/VKTX

Underlying data: Yahoo Finance; company filings with the SEC.